Cipla - Press Release
13/06/2018 19:49
Cipla Limited has informed the Exchange regarding a press release dated Jun 13, 2018, titled "Cipla Receives Final Approval for Generic Isuprelr(Isoproterenol Hydrochloride Injection USP, 0.2mg/mL)".